RxDoctor Payments Data

Eubulus Kerr, MD

Orthopaedic Surgery · Shreveport, LANPI 1730171299

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (49.7%), royalties or licence payments and travel and lodging — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Centinel Spine, LLC at 36.8% of the total. Reporting peaked in 2019 at $12,827 and has fallen 94.9% since, to $653 in 2025.

$33,260in general payments, 2019–2025

Across 70 payments — averaging $475.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Centinel Spine, LLC$12K
  • Integrity Implants Inc. Dba Accelus$9K
  • Nexus Spine, LLC$5K
  • Choice Spine, LLC$4K
  • Alphatec Spine, Inc$1K
  • Kuros Biosciences USA, Inc$738
  • plus $1K from 13 others
$4,409in research payments, 2019–2025

Across 6 payments — averaging $734.83 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Intrinsic Therapeutics$3K
  • GS Solutions, Inc.$1K
  • Centinel Spine, LLC$250

What the payments were for

  • Royalty or licence$9,08227%
  • Consulting fees$16,52550%
  • Travel & lodging$3,79311%
  • Food & beverage$3,62711%
  • Gifts$2201%
  • Entertainment$130%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$33,260 in reported general payments places this provider in the 85th percentile of 286 orthopaedic surgery providers in Louisiana.

See all orthopaedic surgery providers in Louisiana

Medicare billing

Part B allowed, 2024
$288,113
Medicare patients
337
Services billed
2,493

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Omeprazole16$459
Methylprednisolone36$212
Atorvastatin Calcium12$136
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen24$117
Meloxicam16$113
Gabapentin23$86
Tramadol Hcl21$84
Allopurinol12$82
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen14$45
Methocarbamol13$42

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Shreveport

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →